SuperGen to Announce 2009 First Quarter Financial Results April 27, 2009

* Reuters is not responsible for the content in this press release.

Mon Apr 20, 2009 8:00am EDT 

DUBLIN, Calif.--(Business Wire)--
SuperGen Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery
and development of novel cancer therapies, today announced that it will release
its 2009 first quarter financial results on Monday, April 27, 2009. SuperGen's
management team will provide details of the Company's financial results and any
revised outlook for the future. 

A press release will be issued following the close of the market on April 27th.
The Company will host a webcast conference call to discuss the results at 4:30
p.m. ET / 1:30 p.m. PT. The webcast will be accessible via the Investor
Relations section of the Company`s Web site at www.supergen.com. A webcast
replay of the live conference call will be available shortly following the
event. Alternatively, you may access a replay of the conference call by dialing
1-888-286-8010 (domestic) and 1-617-801-6888 (international); replay passcode
number is 71182334. The webcast replay and conference call replay will be
available for 90 days. 

About SuperGen

Based in Dublin, California, SuperGen is a pharmaceutical company dedicated to
the discovery and development of novel cancer therapies. SuperGen is developing
a number of therapeutic anticancer products focused on kinase and cell signaling
inhibitors and DNA methyltransferase inhibitors. For more information about
SuperGen, please visit http://www.supergen.com. 







SuperGen, Inc.
Timothy L. Enns, 925-560-0100
S.V.P., Corporate Communications & Business Development
tenns@supergen.com
Susanna Chau, 925-560-2845
Manager, Investor Relations
schau@supergen.com



Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.